|
| 1 |
Long term recurrence free survival in a stage IV gallbladder cancer treated with chemotherapy plus trastuzumab and salvage liver resection
Mikel Prieto, Mikel Gastaca, Patricia Ruiz, Alberto Ventoso, Ibone Palomares, Arkaitz Perfecto, Andrés Valdivieso
|
|
| 2 |
Circulating Plasmacytoid and Myeloid Dendritic Cells in Breast Cancer Patients: A Pilot Study
Se Hyun Paek, Hyun Goo Kim, Jun Woo Lee, Joohyun Woo, Hyungju Kwon, Jong Bin Kim, Woosung Lim, Je Ryong Kim, Byung-In Moon, Nam-Sun Paik
|
|
| 3 |
HER-2/neu Oncogene Amplification; A Factor for Predicting Response of Platinum-based Combination Chemotherapy in Ovarian Cancers
Yong Beom Kim, Jae Weon Kim, Noh Hyun Park, Yong Sang Song, Soon Beom Kang, Hyo Pyo Lee, Ju Won Roh, Chul Min Lee
|
|
| 4 |
The Expressions of CD117 (c-kit) and Her-2/neu in Malignant Bone and Soft Tissue Tumors
Jin Gyu Jeong, Ik Su Choi, Su In Roh, Cheol Ho Kwak, Sang Eun Kim, Hee Kyung Chang, Jae Do Kim
|
|
| 5 |
Estrogen receptor-α, progesterone receptor, and c-erbB/HER-family receptor mRNA detection and phenotype analysis in spontaneous canine models of breast cancer
Farruk M. Lutful Kabir, Patricia DeInnocentes, Payal Agarwal, Christopher P. Mill, David J. Riese, R. Curtis Bird
J Vet Sci.2017;18(2):149-158. Published online 2017 June 22
DOI: http://dx.doi.org/10.4142/jvs.2017.18.2.149
|
|
| 6 |
Pilot Study of the Clinical Significance of Serum and Urinary HER-2/neu Protein in Bladder Cancer Patients
Taek Sang Kim, Hyun Yul Rhew, Hyun Yong Hwang
Korean J Urol.2011;52(12):815-818. Published online 2011 December 20
DOI: http://dx.doi.org/10.4111/kju.2011.52.12.815
|
|
| 7 |
Evaluation of Intratumoral HER-2 Heterogeneity by Fluorescence In Situ Hybridization in Invasive Breast Cancer: A Single Institution Study
Sarah Lee, Woohee Jung, Soon-Won Hong, Ja Seung Koo
|
|
| 8 |
The Prognostic and Predictive Value of EGFR and HER-2 in Advanced Non-small Cell Lung Cancer Patients Who Are Treated with Cisplatin and Paclitaxel
Jinyoung Yoo, Byoung Yong Shim, Seok Jin Kang
J Lung Cancer.2009;8(1):13-20. Published online 2009 January 10
DOI: http://dx.doi.org/10.6058/jlc.2009.8.1.13
|
|
| 9 |
Comparison of Her-2, EGFR and Cyclin D1 in Primary Breast Cancer and Paired Metastatic Lymph Nodes: An Immunohistochemical and Chromogenic In Situ Hybridization Study
Eun Yoon Cho, Jae Joon Han, Yoon-La Choi, Kyoung-Mee Kim, Young Lyun Oh
|
|
| 10 |
Expression of HER-2/neu and Paxillin in Ductal Carcinoma in situ, Invasive Ductal Carcinoma with Ductal Carcinoma in situ and Mucinous Carcinoma
Sun-Wook Han, Yoon-Young Choi, Hee-Doo Woo, Doo-Min Sohn, Sang-Ho Bae, Gil-Ho Gang, Sung-Yong Kim, Moo-Jun Baek, Cheol-Wan Lim, Moon-Soo Lee, Chang-Ho Kim, Min-Hyuk Lee, Jin-Hyuk Rho, Hyun-Deuk Cho, Mee Hye Oh, Eui-Han Kim, Moo-Sik Cho
J Breast Cancer.2008;11(3):109-115. Published online 2008 September 30
DOI: http://dx.doi.org/10.4048/jbc.2008.11.3.109
|
|
| 11 |
Correlation between the Her-2/neu Status as Determined by Immunohistochemical Analysis and the Serum Her-2/neu Concentration as Determined by the Use of ADVIA Cencaur® Automated Immunoassay in Breast Cancer Patients
Jung-Sun Lee, Won Ki Min, Eun Hwa Park, Woo-Sung Lim, Sung-Lim Choi, Byung-Ho Son, Sung-Bae Kim, Jin-Hee Ahn, Sei-Hyun Ahn
J Breast Cancer.2008;11(3):116-124. Published online 2008 September 30
DOI: http://dx.doi.org/10.4048/jbc.2008.11.3.116
|
|
| 12 |
The Correlation of Serum HER-2/neu and CA15-3 in Patients with Metastatic Breast Cancer
Nae-Kyeong Park, Hee-Doo Woo, Doo-Min Sohn, Sung-Yong Kim, Cheol-Wan Lim, Tae-Youn Choi, Jae-Jun Kim, Min-Hyuk Lee
|
|
| 13 |
Alteration of Estrogen Receptor, Progesterone Receptor, and HER-2 Expression in Breast Cancer after Neoadjuvant Chemotherapy
Jong Won Lee, Wonshik Han, Eunyoung Ko, Jihyoung Cho, So-Youn Jung, Eun-Kyu Kim, Bhumsuk Keam, Seock-Ah Im, Ho-chang Lee, In Ae Park, Seung Keun Oh, Yeo-Kyu Youn, Sung-Won Kim, Ki-Tae Hwang, Dong-Young Noh
J Breast Cancer.2007;10(3):206-210. Published online 2007 September 30
DOI: http://dx.doi.org/10.4048/jbc.2007.10.3.206
|
|
| 14 |
The γ-Synuclein Expression in Breast Cancer and its Correlation with the Expression of the HER-2/neu Gene
Seong Rae Kim, Won Hyuk Choi, Jun Ho Park, Eun Sook Nam, Seong Jin Cho, Chan Heun Park
|
|
| 15 |
Establishment for Reference Range of Serum HER-2/neu in Korean Healthy Women
Jae-Woo Kim, Sung-Yong Kim, Hong-Soo Lee, Hee-Doo Woo, Doo-Min Son, Cheol-Wan Lim, Tae-Youn Choi, Yong-Seog Jang, Jae-Jun Kim, Min-Hyuk Lee
J Breast Cancer.2006;9(4):301-308. Published online 2006 December 31
DOI: http://dx.doi.org/10.4048/jbc.2006.9.4.301
|
|
| 16 |
Expression of Cyclooxygenase-2 in Human Breast Cancer: Relationship with HER-2/neu and other Clinicopathological Prognostic Factors
Eunmi Nam, Soon Nam Lee, Seock-Ah Im, Do-Yeun Kim, Kyoung Eun Lee, Sun Hee Sung
|
|
| 17 |
Correlation of the Immunohistochemical Coexpression of p53 and HER-2/neu and the Prognosis of Breast Cancer
Jae Ho Park, Seung Jin Kim, Un Jong Choi, Kwang Man Lee
|
|
| 18 |
Clinical Correlation of HER-2/neu Overexpression in Patients with Breast Cancer
Sung Yong Kim, Tae Yoon Kim, Jae Jun Kim, Chang Ho Kim, Ok Pyung Song, Min Hyuk Lee, Eui Han Kim, Moo Sik Cho
|
|
| 19 |
The Analysis of HER-2/neu Gene Status and Correlation with Other Clinico-Pathologic Factors for Breast Cancer Using Tissue Microarray
Chang Soo Song, Seung Il Kim, Chan Heun Park
|
|
| 20 |
Characteristics of HER-2/neu Oncogene in Korean Women with Early-onset Breast Cancer by Immunohistochemistry and Fluorescence In Situ Hybridization
Doo Ho Choi, Min Hyuk Lee, Yong Hee Ahn, Dong Wha Lee, Dong Bok Shin, Darryl Carter, Bonnie L. King, Bruce G. Haffty
|
|
